Effect of alcohol on viral hepatitis and other forms of liver dysfunction

Clinics in Liver Disease

Volumn 9, Issue 1, 2005, Pages 83-101

  Balasubramanian, Sripriya ^a   Kowdley, Kris V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; INTERFERON; NEVIRAPINE; PROTEINASE INHIBITOR;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; HEMOCHROMATOSIS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INSULIN RESISTANCE; IRON OVERLOAD; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER TOXICITY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; PREVALENCE; REVIEW; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 14844323676     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.10.004     Document Type: Review

References (112)

1. W.R. Kim The burden of hepatitis C in the United States Hepatology 36 5 Suppl 1 2002 S30 S34
2. B.F. Grant Alcohol consumption, alcohol abuse and alcohol dependence. The United States as an example Addiction 89 11 1994 1357 1365
3. C.L. Mendenhall, T. Moritz, and S. Rouster Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group Am J Gastroenterol 88 7 1993 1022 1026
4. R. Befrits, M. Hedman, and L. Blomquist Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease Scand J Gastroenterol 30 11 1995 1113 1118
5. S. Shimizu, K. Kiyosawa, and T. Sodeyama High prevalence of antibody to hepatitis C virus in heavy drinkers with chronic liver diseases in Japan J Gastroenterol Hepatol 7 1 1992 30 35
6. M.E. Coelho-Little, L.J. Jeffers, and D.E. Bernstein Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease Alcohol Clin Exp Res 19 5 1995 1173 1176
7. S.H. Caldwell, X. Li, and R.M. Rourk Hepatitis C infection by polymerase chain reaction in alcoholics: false-positive ELISA results and the influence of infection on a clinical prognostic score Am J Gastroenterol 88 7 1993 1016 1021
8. G.E. Austin, B. Jensen, and J. Leete Prevalence of hepatitis C virus seropositivity among hospitalized US veterans Am J Med Sci 319 6 2000 353 359
9. A.S. Rosman, A. Waraich, and K. Galvin Alcoholism is associated with hepatitis C but not hepatitis B in an urban population Am J Gastroenterol 91 3 1996 498 505
10. S.L. Cromie, P.J. Jenkins, and D.S. Bowden Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titer J Hepatol 25 1996 821 826
11. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 9055 1997 825 832
12. F. Pessione, F. Degos, and P. Marcellin Effect of alcohol consumption on serum hepatitis C virus RNA and histologic lesions in chronic hepatitis C Hepatology 27 1998 1717 1722
13. G. Ostapowicz, K.J. Watson, and S.A. Locarnini Role of alcohol in the progression of liver disease caused by hepatitis C virus infection Hepatology 27 6 1998 1730 1735
14. M. Sata, K. Fukuizumi, and Y. Uchimura Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases J Viral Hepat 3 3 1996 143 148
15. L.B. Seeff, Z. Buskell-Bales, and E.C. Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group N Engl J Med 327 27 1992 1906 1911
16. F. Roudot-Thoraval, A. Bastie, and J.-M. Pawlotsky Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients Hepatology 26 1997 485 490
17. D.L. Thomas, J. Astemborski, and R.M. Rai The natural history of hepatitis C virus infection: host, viral, and environmental factors JAMA 284 2000 450 456
18. D.R. Harris, R. Gonin, and H.J. Alter The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse Ann Intern Med 134 2001 120 124
19. L. Serfaty, O. Chazouilleres, and A. Poujol-Robert Risk factors for cirrhosis in patients with chronic hepatitis C virus infection:results of a case-control study Hepatology 26 3 1997 776 779
20. G. Corrao, and S. Arico Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis Hepatology 27 1998 914 919
21. T. Poynard, V. Ratziu, and F. Charlotte Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C J Hepatology 34 2001 730 739
22. J. Westin, M. Lagging, and F. Spak Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection J Viral Hepat 9 2002 235 241
23. A. Monto, K. Patel, and A. Bostrom Risks of a range of alcohol intake on hepatitis C-related fibrosis Hepatology 39 3 2004 826 834
24. D. Goude, B. Fagerberg, J. Hulthe and on behalf of the AIR study group Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study) Clin Sci 102 2002 345 352
25. S. Kiechl, J. Willeit, and W. Poewe Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ 313 1996 1040 1044
26. F. Cholet, J.B. Nousbaum, and M. Richecoeur Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients Gastroenterol Clin Biol 28 3 2004 272 278
27. S.D. Ryder, W.L. Irving, D.A. Jones Trent Hepatitis C Study Group Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study Gut 53 3 2004 451 455
28. Y. Shintani, H. Fujie, and H. Miyoshi Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 126 3 2004 840 848
29. A. Sud, J.M. Hui, and G.C. Farrell Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index Hepatology 39 5 2004 1239 1247
30. T. Konrad, P. Vicini, and S. Zeuzem Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease Exp Clin Endocrinol Diabetes 107 6 1999 343 349
31. T. Zhang, Y. Li, and J.P. Lai Alcohol potentiates hepatitis C virus replicon expression Hepatology 38 1 2003 57 65
32. B. Gao Interaction of alcohol and hepatitis viral proteins: implication in synergistic effect of alcohol drinking and viral hepatitis on liver injury Alcohol 27 1 2002 69 72
33. S. Pianko, S. Patella, and G. Ostapowicz Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection J Viral Hepat 8 6 2001 406 413
34. A. Colell, C. Garcia-Ruiz, and M. Miranda Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor Gastroenterology 115 6 1998 1541 1551
35. A. Canbay, P. Taimr, and N. Torok Apoptotic body engulfment by a human stellate cell line is profibrogenic Lab Invest 83 5 2003 655 663
36. A. Canbay, A.E. Feldstein, and H. Higuchi Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression Hepatology 38 5 2003 1188 1198
37. S.L. Friedman Stellate cell activation in alcoholic fibrosis-an overview Alcohol Clin Exp Res 23 5 1999 904 910
38. A.I. Cederbaum Iron and CYP2E1-dependent oxidative stress and toxicity Alcohol 30 2 2003 115 120
39. E. Zamara, E. Novo, and F. Marra 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells J Hepatol 40 1 2004 60 68
40. K.M. Chang Immunopathogenesis of hepatitis C virus infection Clin Liver Dis 7 1 2003 89 105
41. A. Ulsenheimer, J.T. Gerlach, and N.H. Gruener Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C Hepatology 37 5 2003 1189 1198
42. M. Nascimbeni, E. Mizukoshi, and M. Bosmann Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees J Virol 77 8 2003 4781 4793
43. F. Chiappelli, M. Kung, and P. Lee Alcohol modulation of human normal T-cell activation, maturation, and migration Alcohol Clin Exp Res 19 1995 539 544
44. G. Szabo Consequences of alcohol consumption on host defence Alcohol Alcohol 34 1999 830 841
45. G. Szabo, P. Mandrekar, and A. Dolganiuc Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels Alcohol Clin Exp Res 25 12 2001 1766 1772
46. S.M. Kamal, C.S. Graham, and Q. He Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis J Infect Dis 189 7 2004 1140 1150
47. N.L. Fowler, J. Torresi, and D.C. Jackson Immune responses in hepatitis C virus infection: the role of dendritic cells Immunol Cell Biol 81 1 2003 63 66
48. C. Bain, A. Fatmi, and F. Zoulim Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection Gastroenterology 120 2001 512 524
49. G. Szabo, P. Mandrekar, and A. Dolganiuc Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels Alcohol Clin Exp Res 25 12 2001 1766 1772
50. J. Encke, and J.R. Wands Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization Alcohol Clin Exp Res 24 7 2000 1063 1069
51. P.J. Rowan, S. Tabasi, and M. Abdul-Latif Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C J Clin Gastroenterol 38 6 2004 530 534
52. T. Okazaki, H. Yoshihara, and K. Suzuki Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers Scand J Gastroenterol 29 11 1994 1039 1043
53. K. Ohnishi, S. Matsuo, and K. Matsutani Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers Am J Gastroenterol 91 7 1996 1374 1379
54. M. Tabone, L. Sidoli, and C. Laudi Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy J Viral Hepat 9 4 2002 288 2894
55. K.E. Sherman, S.D. Rouster, and C. Mendenhall Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease Hepatology 30 1999 265 270
56. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2 2004 97 107
57. Centers for Disease Control and Prevention (CDC). Incidence of acute hepatitis B-United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004;51-52: 1252-4
58. J. Larkin, M.M. Clayton, and J. Liu Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice Hepatology 34 4 Pt 1 2001 792 797
59. H. Nomura, J. Hayashi, and W. Kajiyama Alcohol consumption and seroconversion from hepatitis B e antigen in the Okinawa Japanese Fukuoka Igaku Zasshi 87 11 1996 237 241
60. L.A. Kondili, M.E. Tosti, and M. Szklo The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania Epidemiol Infect 121 2 1998 391 395
61. G. Corrao, P. Torchio, and A. Zambon Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis Eur J Epidemiol 14 5 1998 447 456
62. T. Murata, H. Takanari, and S. Watanabe Enhancement of chronic viral hepatitic changes by alcohol intake in patients with persistent HBs-antigenemia Am J Clin Pathol 94 3 1990 270 273
63. H. Nomura, S. Kashiwagi, and J. Hayashi An epidemiologic study of effects of alcohol in the liver in hepatitis B surface antigen carriers Am J Epidemiol 128 2 1988 277 284
64. G. Montalto, M. Cervello, and L. Giannitrapani Epidemiology, risk factors, and natural history of hepatocellular carcinoma Ann N Y Acad Sci 963 2002 13 20
65. M.W. Yu, F.C. Hsu, and I.S. Sheen Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers Am J Epidemiol 145 11 1997 1039 1047
66. M.M. Hassan, L.Y. Hwang, and C.J. Hatten Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 5 2002 1206 1213
67. F. Donato, U. Gelatti, and A. Tagger Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy Cancer Causes Control 12 10 2001 959 964
68. J.F. Tsai, J.E. Jeng, and L.Y. Chuang Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study Medicine (Baltimore) 82 5 2003 365 372
69. L.Y. Wang, S.L. You, and S.N. Lu Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan Cancer Causes Control 14 3 2003 241 250
70. T. Poynard, P. Mathurin, C.L. Lai PANFIBROSIS Group A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 3 2003 257 265
71. L. Martin-Carbonero, Y. Benhamou, and M. Puoti Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study Clin Infect Dis 38 1 2004 128 133
72. C. Tural, D. Fuster, and J. Tor Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients J Viral Hepat 10 2 2003 118 125
73. Y. Benhamou, V. Di Martino, and M. Bochet Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy Hepatology 34 2 2001 283 287
74. M. Bonacini Liver injury during highly active antiretroviral therapy: the effect of hepatitis C coinfection Clin Infect Dis 38 Suppl 2 2004 S104 S108
75. L. Martin-Carbonero, M. Nunez, and J. Gonzalez-Lahoz Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine HIV Clin Trials 4 2 2003 115 120
76. M. Puoti, A. Spinetti, and A. Ghezzi Mortality for liver disease in patients with HIV infection: a cohort study J Acquir Immune Defic Syndr 24 3 2000 211 217
77. E. Rosenthal, M. Poiree, C. Pradier GERMIVIC Joint Study Group Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) AIDS 17 12 2003 1803 1809
78. A. Gilbert, and A. Grenet Cirrhose alcoolique hypertrophique pigmentaire C R Soc Biol 10 1896 1078 1108
79. J.N. Feder, A. Gnirke, and W. Thomas A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
80. Y.M. Deugnier, B. Turlin, and L.W. Powell Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases Hepatology 17 1 1993 30 34
81. R. Moirand, F. Kerdavid, and O. Loreal Regulation of ferritin expression by alcohol in a human hepatoblastoma cell line and in rat hepatocyte cultures J Hepatol 23 4 1995 431 439
82. Y. Suzuki, H. Saito, and M. Suzuki Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease Alcohol Clin Exp Res 26 8 Suppl 2002 26S 31S
83. L.G. Valerio Jr, T. Parks, and D.R. Petersen Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury Alcohol Clin Exp Res 20 8 1996 1352 1361
84. A.A. Caro, and A.I. Cederbaum Oxidative stress, toxicology, and pharmacology of CYP2E1 Annu Rev Pharmacol Toxicol 44 2004 27 42
85. D. Wu, and A.I. Cederbaum Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1 Alcohol Clin Exp Res 25 4 2001 619 628
86. T. Castillo, D.R. Koop, and S. Kamimura Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation Hepatology 16 4 1992 992 996
87. N. Nieto, S.L. Friedman, and A.I. Cederbaum Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species Hepatology 35 1 2002 62 73
88. G.M. Brittenham, H. Tsukamoto, and W. Horne Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 96 1 1995 620 630
89. C. Gardi, B. Arezzini, and V. Fortino Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells Biochem Pharmacol 64 7 2002 1139 1145
90. E. Kukielka, and A.I. Cederbaum Ferritin stimulation of lipid peroxidation by microsomes after chronic ethanol treatment: role of cytochrome P4502E1 Arch Biochem Biophys 332 1 1996 121 127
91. A.J. Tector, J.K. Olynyk, and R.S. Britton Hepatic mitochondrial oxidative metabolism and lipid peroxidation in iron-loaded rats fed ethanol Lab Clin Med 126 6 1995 597 602
92. J. Olynyk, P. Hall, and W. Reed A long-term study of the interaction between iron and alcohol in an animal model of iron overload J Hepatol 22 6 1995 671 676
93. L.M. Fletcher, J.L. Dixon, and D.M. Purdie Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis Gastroenterology 122 2 2002 281 289
94. P.C. Adams, and S. Agnew Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings Hepatology 23 4 1996 724 727
95. V. Scotet, M.C. Merour, and A.Y. Mercier Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation Am J Epidemiol 158 2 2003 129 134
96. V.R. Gordeuk African iron overload Semin Hematol 39 4 2002 263 269
97. V. Gordeuk, J. Mukiibi, and S. Hasstedt Iron overload in Africa. Interaction between a gene and dietary iron content N Engl J Med 326 2 1992 95 100
98. V.R. Gordeuk, A. Caleffi, and E. Corradini Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene Blood Cells Mol Dis 31 3 2003 299 304
99. V.M. Moyo, R. Makunike, and I.T. Gangaidzo African iron overload and hepatocellular carcinoma (HA-7-0-080) Eur J Haematol 60 1 1998 28 34
100. V.M. Moyo, I.T. Gangaidzo, and V.R. Gordeuk Tuberculosis and iron overload in Africa: a review Cent Afr J Med 43 11 1997 334 339
101. S.M. Grundy Metabolic complications of obesity Endocrine 13 2 2000 155 165
102. M. Haque, and A.J. Sanyal The metabolic abnormalities associated with non-alcoholic fatty liver disease Best Pract Res Clin Gastroenterol 16 5 2002 709 731
103. J. Ludwig, T.R. Viggiano, and D.B. McGill Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 7 1980 434 438
104. K.R. Falchuk, S.C. Fiske, and R.C. Haggitt Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus Gastroenterology 78 3 1980 535 541
105. E.E. Powell, W.G. Cooksley, and R. Hanson The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1 1990 74 80
106. K.D. Lindor, K.V. Kowdley, and E.J. Heathcote Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial Hepatology 39 3 2004 770 778
107. K. Promrat, G. Lutchman, and G.I. Uwaifo A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis Hepatology 39 1 2004 188 196
108. D.E. Flanagan, V.M. Moore, and I.F. Godsland Alcohol consumption and insulin resistance in young adults Eur J Clin Invest 30 2000 297 301
109. M.J. Davies, D.J. Baer, and J.T. Judd Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial JAMA 287 2002 2559 2562
110. J.B. Dixon, P.S. Bhathal, and P.E. O'Brien Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 1 2001 91 100
111. F. Laine, C. Bendavid, and R. Moirand Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption Hepatology 39 6 2004 1639 1646
112. G.N. Ioannou, N.S. Weiss, and K.V. Kowdley Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study Gastroenterology 125 4 2003 1053 1059